Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medtronic Extended Wear Infusion Set Study
NCT02687256Phase 1Completed
- Sponsor
- Stanford University
- Start
- Mar 2016
- Primary completion
- Nov 2017
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in type 1 diabetes mellitus (T1D) (3 arms), sponsored by Stanford University. Primary endpoint: Time to an infusion set failure due to an occlusion at 1 week. Started Mar 2016; status: completed.
02
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02687256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02687256.